Clinical Trial: A Phase Ia Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of EA5 in Healthy Adult Subjects

U.S., Dec. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07256288) titled 'A Phase Ia Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of EA5 in Healthy Adult Subjects' on Nov. 20.

Brief Summary: This is a single-center, double-blind, placebo-controlled, dose-escalating Phase Ia clinical study designed to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of a single dose of EA5 in healthy adult subjects.

Study Start Date: May 31, 2023

Study Type: INTERVENTIONAL

Condition: Healthy Volunteers

Intervention: DRUG: EA5

All doses of EA5 were administered by IV infusion, using programmable IV infusion pump and IV sets with in-line fil...